VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $469,883 | +23.9% | 9,217 | +21.4% | 0.02% | +35.7% |
| Q2 2023 | $379,144 | +76.3% | 7,592 | +32.3% | 0.01% | +55.6% |
| Q1 2023 | $215,098 | -16.7% | 5,739 | 0.0% | 0.01% | -10.0% |
| Q4 2022 | $258,255 | +174.7% | 5,739 | +45.2% | 0.01% | +150.0% |
| Q3 2022 | $94,000 | +9.3% | 3,953 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $86,000 | +14.7% | 3,953 | +26.8% | 0.00% | +33.3% |
| Q1 2022 | $75,000 | +1.4% | 3,117 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $74,000 | -6.3% | 3,117 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $79,000 | +12.9% | 3,117 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $70,000 | +48.9% | 3,117 | +32.3% | 0.00% | +50.0% |
| Q1 2021 | $47,000 | +14.6% | 2,356 | +51.8% | 0.00% | 0.0% |
| Q4 2020 | $41,000 | -46.8% | 1,552 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $77,000 | – | 1,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |